Pharmagen, Inc.
PHRX
$0.00
$0.000.00%
OTC PK
| 03/31/2014 | 12/31/2013 | 09/30/2013 | 06/30/2013 | 03/31/2013 | |
|---|---|---|---|---|---|
| Net Income | 69.16% | -71.50% | 10.23% | -78.30% | 8.14% |
| Total Depreciation and Amortization | -10.12% | 25.84% | 30.88% | 9.68% | 135.44% |
| Total Amortization of Deferred Charges | -26.05% | 14.83% | 2.50% | 7.33% | 33.31% |
| Total Other Non-Cash Items | -150.78% | 2,966.67% | -104.54% | 505.20% | 68.87% |
| Change in Net Operating Assets | -43.61% | 53.84% | 7,081.48% | -95.98% | 144.89% |
| Cash from Operations | 251.72% | 74.25% | 67.02% | -133.94% | 79.13% |
| Capital Expenditure | -114.48% | -276.62% | -108.11% | 77.30% | -239.58% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -114.48% | -276.62% | -108.11% | 77.30% | 80.78% |
| Total Debt Issued | -- | -100.00% | -90.21% | -68.03% | -52.87% |
| Total Debt Repaid | -79.92% | -127.10% | 140.36% | -977.23% | 58.82% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -20.00% | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | -- |
| Cash from Financing | -46.75% | -14.19% | 283.84% | -112.47% | -55.72% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.93% | 325.15% | 96.22% | -236.22% | 16.69% |